Serratia marcescens is a Gram-negative bacterium of the Enterobacteriaceae family that can
produce numbers of biologically active secondary metabolites. However, our understanding …

Serratia marcescens is a gram-negative, facultatively-anaerobic bacterium and opportunistic
pathogen which produces the red pigment prodigiosin. We employed both batch culture and …

Bacterial secondary metabolites are naturally produced to prevail amongst competitors in a
shared habitat and thus represent a valuable source for antibiotic discovery. The …

Prodigiosin, a secondary metabolite produced by Serratia marcescens, has attracted
attention due to its immunosuppressive, antimicrobial, and anticancer properties. However …

Prodigiosin is a promising secondary metabolite produced mainly by Serratia strains. To
study the global regulatory mechanism of prodigiosin biosynthesis, a mutagenesis library …

The epithelium provides a crucial barrier to infection and its integrity requires efficient wound
healing. Bacterial cells and secretomes from a subset of tested species of bacteria inhibited …

Prodigiosin (PG) is a red tripyrrole pigment from the prodiginine family that has attracted
widespread attention due to its excellent biological activities, including anticancer …

Prodigiosin is a promising secondary metabolite mainly produced by Serratia marcescens.
The production of prodigiosin by S. marcescens is regulated by different kinds of regulatory …

Materials and Methods Bacterial strains and growth. Bacterial strains are listed in Table I.
Bacteria were grown in LB broth (Bertani 1951), supplemented with antibiotics when …

BarA/UvrY, a two-component system and global regulator that controls expression of more
than a hundred of genes involved in virulence, motility, biofilm formation, and central carbon …